iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 71.6% during the third quarter, Holdings Channel reports. The institutional investor owned 570,842 shares of the financial services provider’s stock after selling 1,436,790 shares during the quarter. JPMorgan Chase & Co.’s holdings in iShares Biotechnology ETF were worth $83,115,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the third quarter valued at $29,000. Highline Wealth Partners LLC purchased a new stake in iShares Biotechnology ETF during the third quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth about $36,000. Voisard Asset Management Group Inc. purchased a new position in iShares Biotechnology ETF in the third quarter valued at about $59,000. Finally, Aptus Capital Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 36.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock valued at $62,000 after acquiring an additional 114 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $132.91 on Friday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The stock’s 50 day simple moving average is $138.87 and its 200 day simple moving average is $142.02.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.